Johnson & Johnson (JNJ) Acquisitions (2009 - 2025)

Johnson & Johnson's (JNJ) quarterly Acquisitions came in at $3.0 billion in Q4 2025, up 304000.0% year-on-year from N/an in Q4 2024, and up 304000.0% quarter-over-quarter from $1.0 million in Q3 2025.

Johnson & Johnson (JNJ) Acquisitions (2009 - 2025) Analysis & Trends

Johnson & Johnson has disclosed Acquisitions across 17 years of filings, most recently posting $3.0 billion for Q4 2025.

  • Acquisitions for Q4 2025 came in at $3.0 billion, up 304000.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $17.5 billion (up 223.36% YoY), and the FY2025 annual result was $17.5 billion, up 15.54% from the prior year.
  • Acquisitions came in at $3.0 billion for Q4 2025 at Johnson & Johnson, up from $1.0 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $17.7 billion in Q1 2023 to a low of $1.0 million in Q4 2024.
  • The 5-year median for Acquisitions is $1.8 billion (2024), against an average of $4.5 billion.
  • Across the five-year window, Acquisitions tumbled 99.95% in 2024 and jumped 304000.0% in 2025, its largest moves.
  • Johnson & Johnson's Acquisitions stood at $6.4 billion in 2021, then sank by 96.05% to $252.0 million in 2022, then surged by 653.97% to $1.9 billion in 2023, then sank by 99.95% to $1.0 million in 2024, then surged by 304000.0% to $3.0 billion in 2025.
  • The last three Acquisitions figures came in at $3.0 billion (Q4 2025), $1.0 million (Q3 2025), and $14.5 billion (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -1.89 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 8.78 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 109.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 65.00 Mn
10 Novartis Ag 109.78 Bn 109.09 Bn - -

Historic Data

Download Data
DateValue
Dec 28, 2025 3.04 Bn
Sep 28, 2025 1.00 Mn
Jun 29, 2025 14.46 Bn
Dec 29, 2024 1.00 Mn
Sep 29, 2024 1.80 Bn
Jun 30, 2024 1.80 Bn
Mar 31, 2024 1.81 Bn
Dec 31, 2023 1.90 Bn
Jan 1, 2023 17.65 Bn
Apr 3, 2022 252.00 Mn
Jan 3, 2021 6.37 Bn
Jun 28, 2020 800.00 Mn
Mar 29, 2020 939.00 Mn
Dec 29, 2019 4.90 Bn
Sep 29, 2019 216.00 Mn
Jun 30, 2019 3.40 Bn
Mar 31, 2019 1.68 Bn
Sep 30, 2018 675.00 Mn
Jul 1, 2018 140.00 Mn
Apr 1, 2018 82.00 Mn